Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus Cream 1% in Pediatric Facial Atopic Dermatitis
NCT00130364Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD) (2 arms), sponsored by Novartis. Primary endpoint: Percentage of patients with a facial Investigator's Global Assessment (IGA) score of 0 or 1. Started Aug 2005; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00130364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130364.